Repligen Q4 Adjusted EPS $0.33, Inline, Sales $155.74M Beat $155.39M Estimate
Portfolio Pulse from Benzinga Newsdesk
Repligen (NASDAQ:RGEN) reported Q4 earnings of $0.33 per share, meeting analyst estimates, and sales of $155.74M, slightly beating the $155.39M estimate. This represents a 51.47% decrease in earnings and a 16.61% decrease in sales from the same period last year.
February 21, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Repligen reported Q4 earnings per share of $0.33, aligning with estimates, and sales of $155.74M, slightly above expectations. However, both earnings and sales have decreased significantly compared to the previous year.
While Repligen's earnings per share met analyst expectations and sales slightly exceeded estimates, the significant year-over-year decrease in both earnings and sales could concern investors. However, the fact that expectations were met might mitigate negative reactions in the short term, leading to a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100